OSRH

MKT CAP:$18M

OSR Holdings, Inc.

Market Cap

$18M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.60+$0.01 (+0.98%)

Apr 23, 2026

Company Details

OSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesse...

CEO

Kuk Hyoun Hwang

IPO Date

Mar 21, 2023

Website

www.osr-holdings.com

Key Metrics TTM

Revenue

$761.3K

— YoY

Net Income

-$12M

EPS (Diluted)

-$2.59

Free Cash Flow

-$2M

Revenue / Share

$0.17

Gross Margin

22.2%

Operating Margin

-618.2%

Net Margin

-1528.6%

FCF Margin

-236.7%

P/S

23.4x

P/E

—

Earnings Reports

FY 2025

Mar 31, 2026

$3MEPS -$4.02

Q1 2025

May 20, 2025

$761.3KEPS -$2.54

Q2 2024

Aug 19, 2024

$0EPS -$0.02

Q1 2024

May 15, 2024

$0EPS -$0.01

FY 2023

Apr 17, 2024

$0EPS $0.07

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 21	$0	$0	-$124
Q2 21	$0	$0	-$2.7K
Q3 21	$0	$0	-$119
Q4 21	$0	$0	-$322
Q1 22	$0	$0	-$126
Q2 22	$0	$0	-$988
Q3 22	$0	$0	-$20.0K
Q4 22	$0	$0	-$14.3K
Q1 23	$0	$0	-$278.1K
Q2 23	$0	$0	-$280.3K
Q3 23	$0	$0	-$410.4K
Q4 23	$0	$0	-$861.9K
Q1 24	$0	$0	-$450.8K
Q2 24	$0	$0	-$475.5K
Q1 25	$761.3K	$168.7K	-$3M

Valuation

Quarter	P/S	P/E
Q1 21	—	—
Q2 21	—	—
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	1218.7x
Q2 23	—	246.1x
Q3 23	—	162.0x
Q4 23	—	146.9x
Q1 24	—	185.2x
Q2 24	—	—
Q1 25	5.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$5.2K	$5.2K
Q4 21	-$121	-$121
Q1 22	-$126	-$126
Q2 22	-$6.9K	-$6.9K
Q3 22	$3.8K	$3.8K
Q4 22	-$952	-$952
Q1 23	-$48.4K	-$48.4K
Q2 23	-$347.6K	-$347.6K
Q3 23	-$143.2K	-$143.2K
Q4 23	-$279.5K	-$279.5K
Q1 24	-$41.8K	-$41.8K
Q2 24	-$1M	-$1M
Q1 25	-$64.1K	-$64.1K

Capital Expenditures

Quarter	CapEx
Q3 21	$4
Q4 21	$0
Q1 22	$0
Q2 22	$0
Q3 22	$0
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q1 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	+1.6%
Q2 22	—	-64.0%
Q3 22	—	+16725.2%
Q4 22	—	+4326.1%
Q1 23	—	+220615.9%
Q2 23	—	+28267.7%
Q3 23	—	+1949.9%
Q4 23	—	+5947.5%
Q1 24	—	+62.1%
Q2 24	—	+69.7%
Q1 25	—	+796.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$0	—
Q4 21	$0	—
Q1 22	$0	—
Q2 22	$0	—
Q3 22	$0	—
Q4 22	$0	—
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$0	—
Q1 24	$0	—
Q2 24	$0	—
Q1 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	SG&A
Q1 21	—	$124
Q2 21	$2.7K	—
Q3 21	$119	—
Q4 21	$322	—
Q1 22	$126	—
Q2 22	$988	—
Q3 22	$20.0K	—
Q4 22	$14.3K	—
Q1 23	$278.1K	—
Q2 23	$280.3K	—
Q3 23	$410.4K	—
Q4 23	$861.9K	—
Q1 24	$450.8K	—
Q2 24	$475.5K	—
Q1 25	$713.0K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 21	$4.8K	$0	$4.8K
Q2 22	$74.2K	$0	$74.2K
Q3 22	$68.8K	$0	$68.8K
Q4 22	$124.5K	$0	$124.5K
Q1 23	$348.8K	$0	$348.8K
Q2 23	$1.2K	$0	$1.2K
Q3 23	$58.0K	$0	$58.0K
Q4 23	$15.4K	$0	$15.4K
Q1 24	$3.6K	$0	$3.6K
Q2 24	$119.1K	$0	$119.1K
Q3 24	$12.2K	$0	$12.2K
Q4 24	$66.1K	$0	$66.1K
Q1 25	$2M	$0	$2M
Q2 25	$2M	$0	$2M
Q3 25	$2M	$0	$2M
Q4 25	$2M	$0	$2M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 21	8M	—	—
Q2 21	8M	0.0%	—
Q3 21	8M	+0.5%	—
Q4 21	8M	-0.5%	—
Q1 22	8M	+0.5%	+0.5%
Q2 22	8M	0.0%	+0.5%
Q3 22	8M	0.0%	0.0%
Q4 22	9M	+14.2%	+14.8%
Q1 23	9M	0.0%	+14.2%
Q2 23	9M	0.0%	+14.2%
Q3 23	9M	0.0%	+14.2%
Q4 23	7M	-18.2%	-18.2%
Q1 24	6M	-24.1%	-37.9%
Q2 24	4M	-28.1%	-55.4%
Q1 25	4M	+10.9%	-50.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 21	—	—
Q2 21	—	—
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	$0	2
Q1 23	$0	2
Q2 23	$0	2
Q3 23	$0	2
Q4 23	$0	2
Q1 24	$0	2
Q2 24	$0	2
Q1 25	$152.3K	5

Revenue / Employee